Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Ethan Cerami, Nikolaus Schultz

Celebrating the 10th Anniversary

A decade of discoveries in Cancer Discovery. For the community. By the Community.

  • Research
  • Authors
  • Research Community
  • Research
  • Authors
  • Research Community

Authors

Their impactful studies. In their words.

Ethan Cerami, PhD
Dana-Farber Cancer Institute
Nikolaus Schultz, PhD
Memorial Sloan Kettering Cancer Center

Our Cancer Discovery paper literally put cBioPortal on the map. It's been an amazing ride, and we are so grateful to Cancer Discovery and everyone else who has supported the platform over the past ten years.

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
May 2012

 

Q: What was the origin of the cBioPortal?

A: The cBioPortal was originally developed at Memorial Sloan Kettering Cancer Center (MSKCC) to help analyze genomic data generated by The Cancer Genome Atlas (TCGA) project. We first developed cBioPortal as an exploratory data analysis (EDA) platform to help us do our own research, but once we started to show it to others within TCGA and MSKCC, we realized that others found it quite useful too, and we received a flood of feature requests. We also realized that cBioPortal filled a unique niche—enabling translational researchers and clinicians to more easily explore very large genomic data sets without requiring any bioinformatics expertise. cBioPortal continues to fill this niche, and we have thousands of dedicated users all over the world now!

 

Q: What were some of the unexpected challenges or successes in developing this resource?

A: When we first started cBioPortal, we really had no idea that it would become so widely used. With success came significant challenges, including how to scale the system, how to prioritize user requests, how to provide user training and education, how to collaborate across multiple cancer centers, and how to secure long-term funding. To meet these challenges, we are very fortunate to have such a dedicated user base, and steady funding from the NCI Informatics Technology for Cancer Research (ITCR) program, Memorial Sloan Kettering Cancer Center, and Dana-Farber Cancer Institute. The platform has also morphed into a true open source platform, and we now integrate contributions from developers across the globe. An ongoing challenge is the curation of publicly available genomic data sets to make them available in cBioPortal. We need to make it easier for users to contribute data sets directly, and we could work with journals to ensure that genomic data sets and accompanying clinical data are made available and accessible with publication.

 

Q: What has been the paper’s greatest impact in the years to follow?

A: Our Cancer Discovery paper literally put cBioPortal on the map…every hour of every day, someone is on cBioPortal, and we now get emails from all over the world. In fact, over 300K unique users access cBioPortal each year, and we have continued to see study growth across the globe. In addition, countless private instances of cBioPortal exist around the world at research institutions, hospitals, and pharmaceutical companies. It's been an amazing ride, and we are so grateful to Cancer Discovery and everyone else who has supported the platform over the past ten years. We also remain excited about the future of cBioPortal, and we now have a dedicated team across multiple cancer centers that works nonstop adding new features, responding to user queries, doing live webinars, and dreaming about the future of the platform.

Read the article

Back to top

 


Cancer Discovery Editorial Office
American Association for Cancer Research  |  Publishing Division
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 446-7297  |  E-mail:  cancerdiscovery@aacr.org

  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement